RESEARCHERS FIND LOW COST DRUG WIPES OUT DRUG RESISTANT TB, BUT WORRY IT MAY NOT REACH PATIENTS IN NEED An off-patent anti-inflammatory drug that costs around two cents for a daily dose in d... Read more
Could reduce treatment by more than a year for some patients A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinic... Read more
Kills 2 million people annually A two-drug combination is one of the most promising advances in decades for the treatment of tuberculosis (TB) — a disease that kills 2 million people a... Read more
WHO-endorsed test deployed in battle against tuberculosis in Malawi. On World TB Day, global NGO Project HOPE says new technology has the potential to revolutionize the speedy and accurate d... Read more